Compared with unmodified F127, the concentration range exhibiting sol–gel transition increased for the CL 4 -F127-CL 4 (F-CL4); however, it decreased for the CL 12 -F127-CL 12 (F-CL12), even though both F-CL4 and F-CL12 were hydrophobically modified by the oligocaprolactone (OCL). To understand the abnormal behavior of the OCL end-capped F127, the difference in basic nanoassemblies among the F127, F-CL4, and F-CL12 were investigated at a low concentration of 0.10 wt % as well as at high concentrations exhibiting sol–gel transitions. Dynamic mechanical analysis, 13 C NMR spectroscopy, hydrophobic dye solubilization, dynamic light scattering, microcalorimetry, and transmission electron microscopy suggested that F127’s undergo a unimer-to-micelle transition, whereas F-CL4’s undergo unimer-to-vesicle transition as the temperature increased. On the other hand, F-CL12’s with relatively large end-capped OCL formed aggregated micelle structures that undergo temperature-sensitive conformation changes. In addition, as the temperature increased, sol-to-gel-to-syneresis and gel-to-sol-to-gel-to-syneresis transitions were observed for F-CL4 and F-CL12 aqueous solutions, respectively, whereas a sol-to-gel-to-sol transition was observed for Pluronic F127 aqueous solution. The findings suggest that the end-capping of F127 by OCL induces changes in nanoassemblies, which play a key role in different physicochemical properties leading to the abnormal phase behavior.
No takes yet. Share an insight, caveat, or question.
Jung et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: